Search research articles
Contact Us
Filters
Showing results (81-90 of 341) with videos related to
Page
of 35
Sort By:
Aging
|
December 21, 2019
CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
Weikai Xiao, Shaoquan Zheng, Yutian Zou, et al.
Therapeutic Advances in Medical Oncology
|
December 7, 2020
PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer
Bo Chen, Jianguo Lai, Danian Dai, et al.
Cancer Medicine
|
October 6, 2017
Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast
Xiaofang He, Feng Ye, Mei Li, et al.
Journal of Cancer Research and Therapeutics
|
October 14, 2015
Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma
Hailin Tang, Qing Liu, Xiaoping Liu, et al.
Science China. Life Sciences
|
June 20, 2013
O-glycan profiling of serum glycan for potential renal cancer biomarkers
Yi Gao, Fei Ma, Wei Zhang, et al.
Frontiers in Cell and Developmental Biology
|
April 3, 2024
Causal relationship between immune cells and prostate cancer: a Mendelian randomization study
Zhipeng Ye, Xinpei Deng, Jinhui Zhang, et al.
International Journal of Surgery (London, England)
|
January 22, 2026
Isocucurbitacin B targets STAT3 to induce ferroptosis and promote anti-PD1 immunotherapy responses in breast cancer
Jianbo Zhou, Heng Zhang, Wei-Wei Pan, et al.
Frontiers in Pharmacology
|
May 6, 2015
Asymmetric author-topic model for knowledge discovering of big data in toxicogenomics
Ming-Hua Chung, Yuping Wang, Hailin Tang, et al.
Cancer Letters
|
October 9, 2020
Corrigendum to "Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22" [Canc. Lett. 340 (1) (Oct 28, 2013) 72-81]
Hailin Tang, Yanan Kong, Jiaoli Guo, et al.
Medical Oncology (Northwood, London, England)
|
August 15, 2014
Co-expression of EGFR and CK5/6 in primary squamous cell carcinoma of the breast
Jin Wang, Xinke Zhang, Jiehua He, et al.
Page
of 35
Search research articles
Search
Showing results (81-90 of 341) with videos related to
Sort By:
Page
of 35
Aging
|
December 21, 2019
CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
Weikai Xiao, Shaoquan Zheng, Yutian Zou, et al.
Therapeutic Advances in Medical Oncology
|
December 7, 2020
PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer
Bo Chen, Jianguo Lai, Danian Dai, et al.
Cancer Medicine
|
October 6, 2017
Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast
Xiaofang He, Feng Ye, Mei Li, et al.
Journal of Cancer Research and Therapeutics
|
October 14, 2015
Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma
Hailin Tang, Qing Liu, Xiaoping Liu, et al.
Science China. Life Sciences
|
June 20, 2013
O-glycan profiling of serum glycan for potential renal cancer biomarkers
Yi Gao, Fei Ma, Wei Zhang, et al.
Frontiers in Cell and Developmental Biology
|
April 3, 2024
Causal relationship between immune cells and prostate cancer: a Mendelian randomization study
Zhipeng Ye, Xinpei Deng, Jinhui Zhang, et al.
International Journal of Surgery (London, England)
|
January 22, 2026
Isocucurbitacin B targets STAT3 to induce ferroptosis and promote anti-PD1 immunotherapy responses in breast cancer
Jianbo Zhou, Heng Zhang, Wei-Wei Pan, et al.
Frontiers in Pharmacology
|
May 6, 2015
Asymmetric author-topic model for knowledge discovering of big data in toxicogenomics
Ming-Hua Chung, Yuping Wang, Hailin Tang, et al.
Cancer Letters
|
October 9, 2020
Corrigendum to "Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22" [Canc. Lett. 340 (1) (Oct 28, 2013) 72-81]
Hailin Tang, Yanan Kong, Jiaoli Guo, et al.
Medical Oncology (Northwood, London, England)
|
August 15, 2014
Co-expression of EGFR and CK5/6 in primary squamous cell carcinoma of the breast
Jin Wang, Xinke Zhang, Jiehua He, et al.
Page
of 35